MSC - OneBiome UX Pilot Study (OneBiome)

Evaluating the User Experience of the OneBiome Consumers Value Journey Service Offered to the 1000 Days and Young Children Consumers Market

Evaluating the user (pregnant women and parents of young children) experience of the OneBiome consumers value journey service offered to the 1000 days and young children consumers market

Study Overview

• Status: Completed
• Conditions: Microbial Colonization
• Intervention / Treatment: Other: OneBiome microbiome profiling service

Detailed Description

The OneBiome service aims to empower consumers with microbiome science in a friendly/consumer centric manner. The investigators wants to show that microbiome data can be used as an estimate of consumer's health and can be translated into actionable insights. The investigators aim to pilot a consumers' insight study to measure the perception/sentiments of this service in the Singapore market by recruiting study subjects from local public/private hospitals.

• Study Type: Interventional
• Enrollment (Actual): 90
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Singapore
  • Singapore, Singapore, 229899
    • KK Women's and Children's Hospital
  • Singapore, Singapore, 228510
    • Mount Elizabeth Medical Centre

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 1 second and older (Child, Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

1. Pregnant women who are in the third trimester, or children from birth to 5 years of age
2. Pregnant women or parents of children should have access to the internet and a smartphone or tablet to access the OneBiome mobile friendly website.
3. Pregnant women or parents of children should be able to comprehend the content in the OneBiome mobile friendly website and complete the questionnaires in English.
4. Pregnant women and parents of children should stay in Singapore and remain contactable should they decide to do two microbiome assessments within 8 weeks

Exclusion Criteria:

1. Children born prematurely
2. Incapability of the pregnant women or parents of children to access OneBiome mobile friendly website and complete the questionnaires in English.
3. Any other family member is enrolled in the study
4. Incapability of the pregnant women or parents of children to comply with study protocol or Investigator's uncertainty about the willingness or ability of the pregnant women or parents of children to comply with the protocol requirements

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Health Services Research
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Pregnant women or children 0-5 years of age; Pregnant women in third trimester or children 0-5 years of age	Other: OneBiome microbiome profiling service; participants will be asked to complete the user experience of the OneBiome service

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Overall user experience of the OneBiome microbiome profiling service	Pregnant women and parents of young children reported overall user experience of the OneBiome microbiome profiling service, i.e. average rating of the four following UX surveys1) overall experience of kit discovery (from unboxing to shipment); 2) ease of use of the stool collection kit; 3) overall user experience of the OneBiome web platform; 4) overall user experience of reading and understanding the microbiome analysis report.	Approximately 8 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
User experience of different "steps/ phases" of the OneBiome consumers value journey service	Pregnant women and parents of young children reported user experience of different "steps/ phases" of the OneBiome consumers value journey service, including 'kit discovery, 'kit usage', 'web platform', 'evaluation of report', 'evaluation of service' and ''evaluation of consumer's motivation and consumption behaviour habits'	Approximately 8 weeks
Healthcare professional (HCP) reported overall experience of the OneBiome consumers value journey service	HCP reported overall user experience of the OneBiome microbiome profiling service	Approximately 8 weeks
HCP reported usefulness of microbiome data	HCP reported usefulness of microbiome data for their general practice based on user experience interaction between HCP and pregnant women and parents of young children	Approximately 8 weeks

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Microbiome composition of the participants	Microbiome composition in the stool sample of the subject which will be included in the microbiome analysis report to be shared with subject/ parent's subject.	Approximately 8 weeks
Association between microbiome composition and known factors that influence the microbiome	Association between microbiome composition and known factors that influence the microbiome in early life including mode of delivery, antibiotic prophylaxis, infant feeding patterns and diet.	Approximately 8 weeks
Food frequency questionnaire translation into food groups	FFQ data at the beginning and at the end of the study based on translation of FFQ into food groups according to the healthy plate guideline from the Health Promotion Board.	Approximately 8 weeks
Association between gut health parameters, stool images, microbiome composition and dietary patterns	Association between gut health parameters (symptoms, stool consistency, frequency and color, gastrointestinal infection, antibiotic intake) and stool images from participants, and microbiome composition and dietary patterns	Approximately 8 weeks

Collaborators and Investigators

• Sponsor: Danone Asia Pacific Holdings Pte, Ltd.
• Collaborators: KK Women's and Children's Hospital; Chiang Children's Allergy and Asthma Clinic; The Child and Allergic Clinic
• Investigators: Principal Investigator: Bee Wah Lee, MD, The Child and Allergy Clinic; Principal Investigator: Wen Chin Chiang, MD, Chiang Children's Allergy and Asthma Clinic; Principal Investigator: Anne Goh, MD, KK Women's and Children's Hospital

Study record dates

Study Major Dates

• Study Start (Actual): September 1, 2021
• Primary Completion (Actual): March 19, 2022
• Study Completion (Actual): April 29, 2022

Study Registration Dates

• First Submitted: August 1, 2021
• First Submitted That Met QC Criteria: August 1, 2021
• First Posted (Actual): August 5, 2021

Study Record Updates

• Last Update Posted (Actual): January 27, 2023
• Last Update Submitted That Met QC Criteria: January 26, 2023
• Last Verified: January 1, 2023

More Information

Terms related to this study

• Keywords: OneBiome; Consumer insights; User experience
• Additional Relevant MeSH Terms: Pathologic Processes; Disease Attributes; Infections; Communicable Diseases
• Other Study ID Numbers: SBB20R&33310

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No